Cytek Biosciences News

Cytek Biosciences Analyst Ratings

BenzingaMar 6 09:29 ET

Piper Sandler Reaffirms Their Buy Rating on Cytek Biosciences (CTKB)

TipRanksMar 6 07:36 ET

Cytek Biosciences (CTKB) Gets a Buy From Piper Sandler

TipRanksFeb 29 07:48 ET

Cytek Biosciences: A Strong Buy Rating Backed by Solid Financials and Strategic Growth Initiatives

TipRanksFeb 28 22:35 ET

TD Cowen Reaffirms Their Buy Rating on Cytek Biosciences (CTKB)

TipRanksJan 8 13:35 ET

Piper Sandler Keeps Their Buy Rating on Cytek Biosciences (CTKB)

TipRanksDec 18, 2023 07:46 ET

Stephens & Co. Initiates Coverage On Cytek Biosciences With Overweight Rating, Announces Price Target of $9

BenzingaDec 14, 2023 05:46 ET

Cytek Biosciences Analyst Ratings

BenzingaDec 14, 2023 05:45 ET

Analysts Are Bullish on These Healthcare Stocks: Cytek Biosciences (CTKB), DENTSPLY SIRONA (XRAY)

TipRanksNov 16, 2023 08:20 ET

Morgan Stanley Maintains Equal-Weight on Cytek Biosciences, Lowers Price Target to $7

BenzingaNov 9, 2023 09:02 ET

Cytek Biosciences Analyst Ratings

BenzingaNov 9, 2023 09:01 ET

Cytek Biosciences Maintains Strong Market Position Despite Economic Challenges: A Buy Rating Analysis

TipRanksNov 7, 2023 20:05 ET

Morgan Stanley Maintains Equal-Weight on Cytek Biosciences, Lowers Price Target to $8

BenzingaOct 24, 2023 08:27 ET

Cytek Biosciences Analyst Ratings

BenzingaOct 24, 2023 08:26 ET

Piper Sandler Maintains Overweight on Cytek Biosciences, Lowers Price Target to $10

BenzingaOct 16, 2023 13:21 ET

Cytek Biosciences Analyst Ratings

BenzingaOct 16, 2023 13:20 ET

Cytek Biosciences (CTKB) Receives a Buy From Piper Sandler

TipRanksAug 14, 2023 09:25 ET

Piper Sandler Sticks to Its Buy Rating for Cytek Biosciences (CTKB)

TipRanksAug 9, 2023 07:26 ET

Cytek Biosciences Analyst Ratings

BenzingaJul 19, 2023 05:02 ET

Morgan Stanley Adjusts Price Target on Cytek Biosciences to $13 From $14, Maintains Equal-Weight Rating

MT NewswiresMay 11, 2023 09:30 ET